Suppr超能文献

E3 泛素连接酶介导的骨形成和肿瘤发生的调节。

E3 ubiquitin ligase-mediated regulation of bone formation and tumorigenesis.

机构信息

Laboratory of Osteoblast Biology and Pathology, INSERM U606, Paris, France.

出版信息

Cell Death Dis. 2013 Jan 17;4(1):e463. doi: 10.1038/cddis.2012.217.

Abstract

The ubiquitination-proteasome and degradation system is an essential process that regulates protein homeostasis. This system is involved in the regulation of cell proliferation, differentiation and survival, and dysregulations in this system lead to pathologies including cancers. The ubiquitination system is an enzymatic cascade that mediates the marking of target proteins by an ubiquitin label and thereby directs their degradation through the proteasome pathway. The ubiquitination of proteins occurs through a three-step process involving ubiquitin activation by the E1 enzyme, allowing for the transfer to a ubiquitin-conjugated enzyme E2 and to the targeted protein via ubiquitin-protein ligases (E3), the most abundant group of enzymes involved in ubiquitination. Significant advances have been made in our understanding of the role of E3 ubiquitin ligases in the control of bone turnover and tumorigenesis. These ligases are implicated in the regulation of bone cells through the degradation of receptor tyrosine kinases, signaling molecules and transcription factors. Initial studies showed that the E3 ubiquitin ligase c-Cbl, a multi-domain scaffold protein, regulates bone resorption by interacting with several molecules in osteoclasts. Further studies showed that c-Cbl controls the ubiquitination of signaling molecules in osteoblasts and in turn regulates osteoblast proliferation, differentiation and survival. Recent data indicate that c-Cbl expression is decreased in primary bone tumors, resulting in excessive receptor tyrosine kinase signaling. Consistently, c-Cbl ectopic expression reduces bone tumorigenesis by promoting tyrosine kinase receptor degradation. Here, we review the mechanisms of action of E3 ubiquitin ligases in the regulation of normal and pathologic bone formation, and we discuss how targeting the interactions of c-Cbl with some substrates may be a potential therapeutic strategy to promote osteogenesis and to reduce tumorigenesis.

摘要

泛素-蛋白酶体和降解系统是调节蛋白质稳态的一个重要过程。该系统参与细胞增殖、分化和存活的调节,该系统的失调导致包括癌症在内的病理学。泛素化系统是一种酶级联反应,通过泛素标签介导靶蛋白的标记,并通过蛋白酶体途径指导其降解。蛋白质的泛素化通过三步过程发生,涉及 E1 酶对泛素的激活,允许通过泛素连接酶(E2)和靶向蛋白转移,E3 是参与泛素化的最丰富的酶类群。我们对 E3 泛素连接酶在控制骨转换和肿瘤发生中的作用的理解取得了重大进展。这些连接酶通过降解受体酪氨酸激酶、信号分子和转录因子而参与骨细胞的调节。初步研究表明,多结构域支架蛋白 c-Cbl 的 E3 泛素连接酶通过与破骨细胞中的几种分子相互作用来调节骨吸收。进一步的研究表明,c-Cbl 控制成骨细胞中信号分子的泛素化,从而调节成骨细胞的增殖、分化和存活。最近的数据表明,原代骨肿瘤中 c-Cbl 的表达降低,导致受体酪氨酸激酶信号过度。一致地,c-Cbl 通过促进酪氨酸激酶受体降解来减少骨肿瘤的发生。在这里,我们综述了 E3 泛素连接酶在调节正常和病理性骨形成中的作用机制,并讨论了靶向 c-Cbl 与某些底物的相互作用可能是促进成骨和减少肿瘤发生的潜在治疗策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17b4/3564004/05420dc31e78/cddis2012217f1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验